Literature DB >> 18211446

The inhibitory effects of local anaesthetics on the vascular flare responses to bradykinin and substance P in human skin.

M P Dias1, D J Newton, G A McLeod, F Khan, J J F Belch.   

Abstract

Bradykinin and substance P are involved in inflammation and act through Gq-protein-coupled receptors. Local anaesthetics inhibit the signalling of these receptors and have potent anti-inflammatory actions. The aim of this study was to investigate the effects of local anaesthetics on the cutaneous flare responses to bradykinin and substance P. Skin blood flow responses to intradermal injections of bradykinin and substance P were assessed in the absence and presence of anaesthetic and analgesic concentrations of lidocaine, levobupivacaine and ropivacaine. All local anaesthetics significantly attenuated the vascular responses to bradykinin (p = 0.001) and substance P (p < 0.001). There were no differences in this effect between the different agents, but anaesthetic concentrations had a greater attenuating effect than analgesic concentrations on the substance P response (p < 0.001). Local anaesthetics may therefore be useful in the suppression of inflammation and the prevention of postoperative hyperalgesia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18211446     DOI: 10.1111/j.1365-2044.2007.05324.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  7 in total

1.  Attempted ultrasound-guided ethanol ablation of a suspected pancreatic pseudocyst in a dog.

Authors:  Ryan A Sadler; Erica L Fields; Jacqueline C Whittemore
Journal:  Can Vet J       Date:  2016-11       Impact factor: 1.008

2.  Maxadilan, the Lutzomyia longipalpis vasodilator, drives plasma leakage via PAC1-CXCR1/2-pathway.

Authors:  Erik Svensjö; Elvira M Saraiva; Rafael Silveira Amendola; Christina Barja-Fidalgo; Marcelo T Bozza; Ethan A Lerner; Mauro M Teixeira; Julio Scharfstein
Journal:  Microvasc Res       Date:  2011-10-19       Impact factor: 3.514

3.  Intra-articular (IA) ropivacaine microparticle suspensions reduce pain, inflammation, cytokine, and substance p levels significantly more than oral or IA celecoxib in a rat model of arthritis.

Authors:  Barrett Rabinow; Jane Werling; Alison Bendele; Jerome Gass; Roy Bogseth; Kelly Balla; Paul Valaitis; Audrey Hutchcraft; Sabine Graham
Journal:  Inflammation       Date:  2015-02       Impact factor: 4.092

4.  Continuous preperitoneal infusion of ropivacaine for postoperative analgesia in patients undergoing major abdominal or pelvic surgeries. A prospective controlled randomized study.

Authors:  Reem Abdelraouf ElSharkawy; Tamer Elmetwally Farahat; Khaled Abdelwahab
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2020-06-15

5.  Short-term results of intrathecal injection of low-dose bupivacaine in outpatients with chronic low back and lower extremity pain.

Authors:  Akifumi Kanai; Takashi Okamoto; Norihito Hayashi; Junko Shimao; Yuki Nagahara; Kaoru Fujii
Journal:  Eur Spine J       Date:  2018-10-26       Impact factor: 3.134

6.  Systemic ropivacaine diminishes pain sensitization processes: a randomized, double-blinded, placebo-controlled, crossover study in healthy volunteers.

Authors:  Yéri Haller; Andreas R Gantenbein; Patrick Willimann; Donat R Spahn; Konrad Maurer
Journal:  Pain Ther       Date:  2014-01-03

7.  Lignocaine Versus Ropivacaine Infiltration for Postpartum Perineal Pain.

Authors:  Jyoti P Deshpande; Girish Y Saundattikar
Journal:  Anesth Essays Res       Date:  2017 Apr-Jun
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.